Free Trial

Anpario (LON:ANP) Issues Quarterly Earnings Results

Anpario logo with Consumer Defensive background

Key Points

  • Anpario reported earnings of GBX 16.87 earnings per share for the quarter, with a return on equity of 8.74% and a net margin of 9.23%.
  • The stock has a current price of GBX 502.80 and has seen a trading range between GBX 286 and GBX 510 over the past year.
  • Shore Capital reiterated a "house stock" rating and Anpario currently has a consensus rating of "Buy" with a target price of GBX 435.
  • MarketBeat previews the top five stocks to own by October 1st.

Anpario (LON:ANP - Get Free Report) posted its earnings results on Wednesday. The company reported GBX 16.87 earnings per share for the quarter, Digital Look Earnings reports. Anpario had a return on equity of 8.74% and a net margin of 9.23%.

Anpario Stock Down 0.4%

Shares of ANP stock opened at GBX 502.80 on Thursday. Anpario has a 12 month low of GBX 286 and a 12 month high of GBX 510. The firm has a market cap of £85.20 million, a PE ratio of 2,058.97 and a beta of 0.58. The stock has a 50 day moving average of GBX 405.10 and a 200-day moving average of GBX 413.60. The company has a quick ratio of 5.16, a current ratio of 6.15 and a debt-to-equity ratio of 0.10.

Analyst Ratings Changes

Separately, Shore Capital reiterated a "house stock" rating on shares of Anpario in a report on Wednesday. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Anpario presently has a consensus rating of "Buy" and a consensus target price of GBX 435.

Get Our Latest Analysis on ANP

About Anpario

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Anpario Right Now?

Before you consider Anpario, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.

While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.